Cargando…
The effectiveness of a novel treatment of TIM‐3(−) NK cells infusion in murine models of immune‐mediated bone marrow failure
BACKGROUND: T‐cell immunoglobulin and mucin‐containing domain (TIM)‐3 exerts its inhibitory effect on NK cells and participates in the immune pathogenesis of SAA. In this study, we aimed to explore a novel treatment method of TIM‐3(+) NK or TIM‐3(−) NK cell infusion in combination with immunosuppres...
Autores principales: | Ding, Shaoxue, Zhang, Tian, Liu, Zixuan, Cui, Yi, Liu, Chunyan, Fu, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492454/ https://www.ncbi.nlm.nih.gov/pubmed/37539556 http://dx.doi.org/10.1002/jcla.24944 |
Ejemplares similares
-
The Effectiveness of Rapamycin Combined with Eltrombopag in Murine Models of Immune-Mediated Bone Marrow Failure
por: Ding, Shaoxue, et al.
Publicado: (2020) -
Bone marrow‐derived mesenchymal stem cells inhibit NK cell function via Tim‐3/galectin‐9 in multiple myeloma patients
por: Liu, Zhao‐Yun, et al.
Publicado: (2023) -
Bone Marrow Plasma Cytokine Signature Profiles in Severe Aplastic Anemia
por: Liu, Bingnan, et al.
Publicado: (2020) -
Effect of TIM-3 Blockade on the Immunophenotype and Cytokine Profile of Murine Uterine NK Cells
por: Tripathi, Sudipta, et al.
Publicado: (2015) -
The Role of Tim-3 on dNK Cells Dysfunction During Abnormal Pregnancy With Toxoplasma gondii Infection
por: Li, Teng, et al.
Publicado: (2021)